Healius Limited (ASX:HLS) Insider Purchases A$20,232.00 in Stock

Healius Limited (ASX:HLSGet Free Report) insider Jennifer (Jenny) Macdonald bought 8,000 shares of the firm’s stock in a transaction on Monday, September 11th. The shares were purchased at an average price of A$2.53 ($1.63) per share, for a total transaction of A$20,232.00 ($13,052.90).

Healius Price Performance

The company has a debt-to-equity ratio of 117.25, a current ratio of 0.55 and a quick ratio of 0.47.

About Healius

(Get Free Report)

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands.

Further Reading

Insider Buying and Selling by Quarter for Healius (ASX:HLS)

Receive News & Ratings for Healius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healius and related companies with MarketBeat.com's FREE daily email newsletter.